BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 16, 2013
View Archived Issues
HE-400 affects multiple pathways linked to IBS
Read More
Novel FabI inhibitors active against resistant S. aureus
Read More
Flatley Discovery Lab nominates drug candidate for cystic fibrosis
Read More
Starpharma's dendrimer-enhanced oxaliplatin shows reduced neurotoxicity in mouse model
Read More
Microbiotix describes activity of antibacterials with dual mechanism of action
Read More
Efficacy seen with PEG-rHuPH20 plus gemcitabine in pancreatic cancer
Read More
Preclinical studies with GLV-1h68 in sarcoma lead to phase I clinical trial
Read More
Hepatitis A virus cellular receptor has prognostic significance in breast cancer
Read More
German and Swiss team presents novel carbohydrate-based vaccines
Read More
Roche discloses new agents for hepatitis B virus infection
Read More
Scientists at Bayer Healthcare patent novel Mnk1 inhibitors
Read More
Daiichi Sankyo synthesizes new EP2 inhibitors
Read More
Novel gp41 peptide mimetics for HIV infection
Read More
Amarantus BioScience reports analytical performance data for the LymPro Test
Read More
DiaGenic provides update on two diagnostic tests for AD
Read More
University Health Network plans phase I safety and pharmacokinetic study of CFI-400945
Read More
Berg and Icahn School of Medicine form pharmaceutical and diagnostic R&D partnership
Read More
QRxPharma expands MoxDuo agreement with Aspen Pharmacare
Read More
Medical Developments submits MAA in Europe for penthrox
Read More
Symphogen and OMT collaborate to develop novel therapeutic candidates
Read More
OncoCyte enters collaboration with Wistar Institute to develop cancer diagnostics
Read More
KineMed and Amgen enter agreement to develop kinetic biomarkers
Read More
Enrollment completed in phase II Arikace study in NTM lung disease
Read More
Reversal of anticoagulation effect of factor Xa inhibition seen with andexanet alfa
Read More
Cel-Sci and Ergomed sign deal for Multikine
Read More
Atterocor gains orphan drug status for ATR-101, initiates clinical program in ACC
Read More
